These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2317157)

  • 1. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.
    Levin RI; Kantoff PW; Jaffe EA
    Arteriosclerosis; 1990; 10(2):198-207. PubMed ID: 2317157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxalic acid alters intracellular calcium in endothelial cells.
    Recht PA; Tepedino GJ; Siecke NW; Buckley MT; Mandeville JT; Maxfield FR; Levin RI
    Atherosclerosis; 2004 Apr; 173(2):321-8. PubMed ID: 15064109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN; Rolton HA; Modi KS; Macdougall AI
    Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S; Hatch M
    Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired endothelial function in isolated human uremic resistance arteries.
    Morris ST; McMurray JJ; Spiers A; Jardine AG
    Kidney Int; 2001 Sep; 60(3):1077-82. PubMed ID: 11532102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chen TW; Lee YH; Chu WY; Young TK
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium taurocholate affects prostacyclin constitutive production by cultured human vascular endothelial cells.
    Calcamuggi G; Lanzio M; Babini G; Martini S; Anfossi G; Emanuelli G
    J Lab Clin Med; 1990 Jun; 115(6):756-60. PubMed ID: 2114471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma oxalate in chronic renal failure and normal subjects: methodological problems.
    Dorhout Mees EJ; Boer P
    Nephron; 1988; 48(3):256-7. PubMed ID: 3352859
    [No Abstract]   [Full Text] [Related]  

  • 14. The cytotoxicity of oxalate, metabolite of ethylene glycol, is due to calcium oxalate monohydrate formation.
    Guo C; McMartin KE
    Toxicology; 2005 Mar; 208(3):347-55. PubMed ID: 15695020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary oxalic acid excretion differs after oral loading of rats with various oxalate salts.
    Hossain RZ; Ogawa Y; Morozumi M; Sugaya K; Hatano T
    Int J Urol; 2003 Jan; 10(1):43-8. PubMed ID: 12534926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalate crystal deposits in renal tubules and cystic changes in 5/6 nephrectomized and normal rats.
    Ono K; Kikawa K
    ASAIO Trans; 1989; 35(3):629-31. PubMed ID: 2597553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells.
    Scheid C; Koul H; Hill WA; Luber-Narod J; Jonassen J; Honeyman T; Kennington L; Kohli R; Hodapp J; Ayvazian P; Menon M
    J Urol; 1996 Mar; 155(3):1112-6. PubMed ID: 8583575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure.
    France NC; Holland PT; Wallace MR
    Clin Chem; 1994 Aug; 40(8):1544-8. PubMed ID: 8044994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.